Patients with relapsed/refractory multiple myeloma could benefit from repeat treatment with drugs their disease has ...

Glucagon-like peptide-1 receptor (GLP-1) agonists, particularly semaglutide, could be effective in reducing alcohol-related ...

Discover a trial in which patients received either IL-2 or a placebo for 5 days, followed by weekly doses for 4 weeks.

CAR T-cell therapy shows promise for solid tumors like glioblastoma. New engineering strategies and clinical trial results ...

NOVEL molecular regulators of rheumatoid arthritis (RA) inflammation were presented as part of a plenary abstract session at ...

Revisto has raised $4m in seed funding to simplify the pharmaceutical industry's marketing compliance processes using AI.

A new report reveals high rates of preventable pregnancy-related cardiovascular deaths, underscoring racial disparities and ...

Testing for low placental growth factor during routine gestational diabetes screening could identify pregnant individuals at ...

No significant difference found between hydrocortisone replacement and prednisone tapering for glucocorticoid discontinuation ...

Average rating / 5. Vote count: No votes so far! Be the first to rate this content.

As the year barrels toward its finish, pharmaceutical marketers and medical affairs teams find themselves faced with familiar decision: how to allocate their remaining budget for maximum impact. The ...

Companies the world over are searching for the best ways to implement AI into their systems, and according to a new report from S&P Global, budgets will continue to be driven into this area. The ...